139 related articles for article (PubMed ID: 36581574)
1. Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.
Wang Q; Yin R; Tang W; Li C; Zheng H; Zhang X; Jin X; Ying M; Fu J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):594-602. PubMed ID: 36581574
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.
Feng T; Lv W; Yuan M; Shi Z; Zhong H; Ling S
World J Surg Oncol; 2019 Mar; 17(1):54. PubMed ID: 30898132
[TBL] [Abstract][Full Text] [Related]
5. Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.
Zhou Z; Ge H; Li Y; Wang D; Güngör C
PLoS One; 2022; 17(6):e0270608. PubMed ID: 35749551
[TBL] [Abstract][Full Text] [Related]
6. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
Suraju MO; Freischlag K; McKeen A; Nayyar A; Thompson D; Gordon DM; Mishra A; Sherman SK; Goffredo P; Hassan I
J Surg Oncol; 2024 Apr; ():. PubMed ID: 38685721
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.
Shafqat H; Ali S; Salhab M; Olszewski AJ
Dis Colon Rectum; 2015 Mar; 58(3):294-303. PubMed ID: 25664707
[TBL] [Abstract][Full Text] [Related]
9. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis.
Kim JA; Choi AH
JAMA Dermatol; 2013 Jul; 149(7):831-8. PubMed ID: 23864085
[TBL] [Abstract][Full Text] [Related]
10. Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
Chen D; Bao X; Zhang R; Ding Y; Zhang M; Li B; Zhang H; Li X; Tong Z; Liu L; Zhou X; Wang S; Cheng X; Zheng Y; Ruan J; Fang W; Zhao P
Br J Cancer; 2021 Sep; 125(7):994-1002. PubMed ID: 34331023
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study.
Cattrini C; Cerbone L; Rubagotti A; Zinoli L; Latocca MM; Messina C; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2019 Aug; 17(4):e724-e732. PubMed ID: 31160193
[TBL] [Abstract][Full Text] [Related]
12. The survival benefit from surgery on patients with large-cell neuroendocrine carcinoma in the lung: a propensity-score matching study.
Jiang H; Xie W; Li X; Wang H; Yu WJ; Chen X
J Cardiothorac Surg; 2023 Jul; 18(1):216. PubMed ID: 37408065
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor resection enhances the survival of pancreatic neuroendocrine carcinoma patients with liver metastasis under the definition of 2019 WHO classification.
Luo W; Zhang T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9201-9212. PubMed ID: 37184680
[TBL] [Abstract][Full Text] [Related]
14. Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Abedallaa N; Tremblay L; Baey C; Fabre D; Planchard D; Pignon JP; Guigay J; Pechoux CL; Soria JC; de Montpreville VT; Besse B
J Thorac Oncol; 2012 Jul; 7(7):1179-83. PubMed ID: 22617247
[TBL] [Abstract][Full Text] [Related]
15. Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis.
Yi C; Li J; Tang F; Ning Z; Tian H; Xiao L; Wang A; Zong Z
Am Surg; 2020 May; 86(5):499-507. PubMed ID: 32684032
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
18. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
19. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients.
Ruo L; Gougoutas C; Paty PB; Guillem JG; Cohen AM; Wong WD
J Am Coll Surg; 2003 May; 196(5):722-8. PubMed ID: 12742204
[TBL] [Abstract][Full Text] [Related]
20. Lymph node status as a prognostic factor after palliative resection of primary tumor for patients with metastatic colorectal cancer.
Li Q; Wang C; Li Y; Li X; Xu Y; Cai G; Lian P; Cai S
Oncotarget; 2017 Jul; 8(29):48333-48342. PubMed ID: 28430643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
